Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lexaria Bioscience (LEXX)
NASDAQ:LEXX
RESEARCH TOOLSreports
Holding LEXX?
Track your performance easily
LEXX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.20 - $6.85
Previous Close$2.09
Volume115.56K
Average Volume (3M)138.36K
Market Cap
$36.48M
Enterprise Value$27.74M
Total Cash (Recent Filing)$8.51M
Total Debt (Recent Filing)$142.59K
Price to Earnings (P/E)―
Beta1.04
Next Earnings
Apr 14, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.13
Shares Outstanding15,810,205
10 Day Avg. Volume162,382
30 Day Avg. Volume138,364
Standard Deviation0.30
R-Squared0.01
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)3.44
Price to Sales (P/S)91.04
Price to Cash Flow (P/CF)-6.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue100.73
Enterprise Value/Gross Profit142.46
Enterprise Value/Ebitda-5.73
Forecast
1Y Price Target
$12.00Price Target Upside474.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Lexaria Bioscience News
PremiumCompany Announcements
Lexaria Bioscience’s DehydraTECH Outshines in Diabetes Study
PremiumCompany Announcements
Lexaria Bioscience Launches Innovative Drug Study
PremiumCompany Announcements
Lexaria Bioscience Advances GLP-1 Study
PremiumCompany Announcements
Lexaria Bioscience Enters GLP-1 Market RacePremiumCompany Announcements
Lexaria Bioscience’s Promising Diabetes Study ResultsOwnership Overview
3.58% Insiders
2.66% Mutual Funds
3.24% Other Institutional Investors
89.96% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
LEXX FAQ
What was Lexaria Bioscience’s price range in the past 12 months?
Lexaria Bioscience lowest stock price was $1.20 and its highest was $6.85 in the past 12 months.
What is Lexaria Bioscience’s market cap?
Currently, no data Available
When is Lexaria Bioscience’s upcoming earnings report date?
Lexaria Bioscience’s upcoming earnings report date is Apr 14, 2023 which is 590 days ago.
How were Lexaria Bioscience’s earnings last quarter?
Lexaria Bioscience released its earnings results on Jan 18, 2023. The company reported -$0.3 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.3.
Is Lexaria Bioscience overvalued?
According to Wall Street analysts Lexaria Bioscience’s price is currently Undervalued.
Does Lexaria Bioscience pay dividends?
Lexaria Bioscience does not currently pay dividends.
What is Lexaria Bioscience’s EPS estimate?
Lexaria Bioscience’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lexaria Bioscience have?
Lexaria Bioscience has 17,452,595 shares outstanding.
What happened to Lexaria Bioscience’s price movement after its last earnings report?
Lexaria Bioscience reported an EPS of -$0.3 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.459%.
Which hedge fund is a major shareholder of Lexaria Bioscience?
Currently, no hedge funds are holding shares in LEXX
---
Lexaria Bioscience Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.00 (474.16% Upside)
$12.00 (474.16% Upside)
Blogger Sentiment
Bullish
LEXX Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Positive
Last 7 Days ▲ 2.6%
Last 30 Days ▲ 0.7%
Last 30 Days ▲ 0.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
58.33%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
91.20%
Trailing 12-Months
Company Description
Lexaria Bioscience
Lexaria Bioscience Corp. engages in the development of strategic partnerships and in the proprietary nutrient infusion technologies for the production of superfoods. It operates through the IP Licensing and Consumer Products segments. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.
---
LEXX Stock 12 Month Forecast
Average Price Target
$12.00
▲(474.16% Upside)
Technical Analysis
Best Analysts Covering LEXX
1 Year
1 Year Success Rate
5/9 ratings generated profit
1 Year Average Return
+78.51%
reiterated a buy rating 2 months ago
Copying Michael Okunewitch's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of +78.51% per trade.
---